Page 17 – Cancer Research UK Cambridge Institute

Antifungal drug eliminates sleeping bowel cancer cells in mice

31st May 2018

An antifungal medication, commonly prescribed for toenail infections, could help eliminate dormant cells within bowel tumours.

Find out more

Prof Greg Hannon elected to EMBO Membership

14th May 2018

Prof Greg Hannon is among 62 outstanding life sciences researchers who have been elected as new members.

Find out more

Institute Director elected as a Fellow of the Royal Society

9th May 2018

Institute Director, Prof Greg Hannon is among the new Fellows announced today by the Royal Society and chosen for their outstanding contributions to science.

Find out more

Patients to benefit from new brain cancer research funding boost

22nd February 2018

Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK.

Find out more

Possible link between breast cancer and asparagine

7th February 2018

Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread, and by restricting it, cancer cells stopped invading other parts of the body in mice.

Find out more

Professor Greg Hannon appointed Director

1st February 2018

On February 1, 2018 Professor Greg Hannon became the third Director of the Cancer Research UK Cambridge Institute – taking over from Professor Simon Tavaré.

Find out more

Dr Nitzan Rosenfeld receives €50,000 Meyenburg Award

28th November 2017

Dr Nitzan Rosenfeld is being honored with the 2017 Meyenburg Award, which carries a €50,000 monetary prize.

Find out more

New imaging technique spots prostate tumours starved of oxygen

24th August 2017

A new imaging technique uncovers oxygen levels in prostate tumours and could lead to a non-invasive way to determine which tumours are more difficult to treat.

Find out more